We designed Fibrobodies®. These proprietary proteins bind selectively to so-called activated myofibroblasts in any type of fibrotic tissue. Fibrobodies® support conjugation of a wide range of payloads to create Fibrobody®-drug Conjugates. We are developing a line-up of Fibrobody®-drug conjugates for the diagnosis and treatment of fibrosis of the liver, kidney, lung and gut.